Search research articles
Contact Us
Filters
Showing results (1381-1390 of 1,433) with videos related to
Page
of 144
Sort By:
Dermatology (Basel, Switzerland)
|
July 14, 2024
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel
Annamaria Offidani, Angelo Valerio Marzano, Ketty Peris, et al.
Journal of the National Cancer Institute
|
May 1, 2019
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
Aleix Prat, Tomás Pascual, Carmine De Angelis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2021
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
N Harbeck, P Rastogi, M Martin, et al.
The Journal of Dermatological Treatment
|
February 6, 2026
Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study
Claudio Bonifati, Giuseppe Argenziano, Serena Lembo, et al.
Plos One
|
August 14, 2020
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis
Emanuele Scala, Matteo Megna, Paolo Amerio, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 26, 2024
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study
C Bonifati, S Lembo, A G Richetta, et al.
NPJ Breast Cancer
|
April 17, 2023
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors
Emma Zattarin, Daniele Presti, Luigi Mariani, et al.
Dermatology and Therapy
|
January 11, 2021
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations
Paolo Gisondi, Marina Talamonti, Andrea Chiricozzi, et al.
The New England Journal of Medicine
|
January 15, 2025
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
Charles E Geyer, Michael Untch, Chiun-Sheng Huang, et al.
Breast Cancer Research and Treatment
|
November 10, 2021
Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 senonetwork breast units autologous fat grafting safety: a multicenter Italian retrospective study
Marco Klinger, Agnese Losurdo, Andrea V E Lisa, et al.
Page
of 144
Search research articles
Search
Showing results (1381-1390 of 1,433) with videos related to
Sort By:
Page
of 144
Dermatology (Basel, Switzerland)
|
July 14, 2024
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel
Annamaria Offidani, Angelo Valerio Marzano, Ketty Peris, et al.
Journal of the National Cancer Institute
|
May 1, 2019
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
Aleix Prat, Tomás Pascual, Carmine De Angelis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2021
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
N Harbeck, P Rastogi, M Martin, et al.
The Journal of Dermatological Treatment
|
February 6, 2026
Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study
Claudio Bonifati, Giuseppe Argenziano, Serena Lembo, et al.
Plos One
|
August 14, 2020
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis
Emanuele Scala, Matteo Megna, Paolo Amerio, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 26, 2024
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study
C Bonifati, S Lembo, A G Richetta, et al.
NPJ Breast Cancer
|
April 17, 2023
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors
Emma Zattarin, Daniele Presti, Luigi Mariani, et al.
Dermatology and Therapy
|
January 11, 2021
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations
Paolo Gisondi, Marina Talamonti, Andrea Chiricozzi, et al.
The New England Journal of Medicine
|
January 15, 2025
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
Charles E Geyer, Michael Untch, Chiun-Sheng Huang, et al.
Breast Cancer Research and Treatment
|
November 10, 2021
Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 senonetwork breast units autologous fat grafting safety: a multicenter Italian retrospective study
Marco Klinger, Agnese Losurdo, Andrea V E Lisa, et al.
Page
of 144